by Steve Bryson PhD | Apr 6, 2021 | Parkinsons
Microbleeds found in the brains of people with Parkinson’s disease by magnetic resonance imaging (MRI) scans were associated with cognitive decline, a study demonstrated. Higher levels of a microbleed-associated biomarker also were found in patients with...
by Steve Bryson PhD | Apr 2, 2021 | Parkinsons
Gocovri (amantadine) more than doubled the daily time on levodopa-based therapies without any dyskinesia — involuntary, uncontrolled movements — in people with Parkinson’s disease compared to those given a placebo, an analysis of data from two Phase 3...
by Steve Bryson PhD | Apr 1, 2021 | Parkinsons
In light of Parkinson’s Awareness Month — starting April 1st — Parkinson Canada is calling for better awareness of the neurodegenerative disorder, while supporting organizations dedicated to helping those impacted by it. This message is made more urgent by...
by Steve Bryson PhD | Apr 1, 2021 | Parkinsons
Several microRNAs found in the blood of people with Parkinson’s disease differed from healthy controls, correlated with disease progression, and were associated with hallmarks of the condition, a study reported. These findings support the use of microRNAs as...
